Skip to main content
Jinoos Yazdany, MD, Rheumatology, San Francisco, CA

JinoosYazdanyMDMPH

Rheumatology San Francisco, CA

Associate Professor, Medicine, UCSF School of Medicine

Dr. Yazdany is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yazdany's full profile

Already have an account?

  • Office

    400 Parnassus Ave
    San Francisco, CA 94143
    Phone+1 415-353-2497
    Fax+1 415-353-2777

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Rheumatology, 2003 - 2006
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2000

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2025
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Accurate Measurement in California’s Safety-Net Health Systems Has Gaps and Barriers  
    Jinoos Yazdany, Urmimala Sarkar, Elaine C Khoong, Health Affairs
  • Psychometric Evaluation of the NIH Patient‐Reported Outcomes Measurement Information System (PROMIS®) in a Multi‐Racial, Multi‐Ethnic Systemic Lupus Erythematosus (SLE...  
    Jinoos Yazdany, Lindsey A Criswell, Arthritis Care & Research
  • Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D  
    Jinoos Yazdany, MD, JAMA
  • Join now to see all

Press Mentions

  • AI Is Changing Medicine: This Is How We Make Sure It Works for Everyone
    AI Is Changing Medicine: This Is How We Make Sure It Works for EveryoneJune 27th, 2022
  • AI Is Transforming Medicine: Here’s How We Make Sure It Works for Everyone
    AI Is Transforming Medicine: Here’s How We Make Sure It Works for EveryoneJune 26th, 2022
  • Risk of Adverse Outcomes Due to COVID-19 May Be Lower with TNF Inhibitor Monotherapy
    Risk of Adverse Outcomes Due to COVID-19 May Be Lower with TNF Inhibitor MonotherapyMay 5th, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Farsi